IXICO PLC (LSE:IXI, OTC:PHYOF) delivered a 13% rise in annual revenue to £6.5 million, driven by new contracts and partnerships. The neuroscience data firm also boosted its cash reserves and narrowed losses for the year.
Solvonis Therapeutics PLC (LSE:SVNS) has raised £1.25 million to advance its programmes tackling addiction, psychiatry, and neurology. The funds will speed up research and strengthen its internal R&D capabilities.
Allergy Therapeutics PLC (AIM:AGY, OTC:AGYTF) says its peanut allergy vaccine continues to show strong results in early clinical testing. The treatment was well tolerated and reduced allergic reactions, with a Phase IIb trial planned for next year.
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has appointed Peter Collins as interim CEO. The company, soon to be renamed CelLBxHealth, is preparing for a major restructuring and funding round later this year.
Anglo Asian Mining Plc (LSE:AAZ, OTC:AGXKF) reported record quarterly copper production of 2,287 tonnes as new mines ramped up. Gold and silver output also increased, with upgraded guidance for the year ahead.
Iofina PLC (AIM:IOF, OTC:IOFNF) hit a record 215.8 tonnes of iodine production in the third quarter, up 32% year-on-year. The company expects to start building its next plant before the end of 2025.
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.